| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | A novel serum carbohydrate marker on mucin 5AC: Values for diagnostic and prognostic indicators for cholangiocarcinoma | Silsirivanit, A Araki, N Wongkham, C Pairojkul, C Narimatsu, Y Kuwahara, K Narimatsu, H Wongkham, S Sakaguchi, N |
2011 | ||||
| 2. | Aberrant glycosylation in cholangiocarcinoma demonstrated by lectin-histochemistry | Somsiri Indramanee Atit Silsirivanit Chawalit Pairojkul Chaisiri Wongkham Sopit Wongkham |
2012 | ||||
| 3. | A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis. | Kanlayanee Sawanyawisuth Atit Silsirivanit Kunlathida Kunlabut Nattawat Tantapotinan Kulthida Vaeteewoottacharn Sopit Wongkham |
2012 | ||||
| 4. | Biomarkers in Bile Duct Cancers: Current Status | Atit Silsirivanit Siriporn Proungvitaya Khon Kaen University - Faculty of Associated Medical Sciences Kanlayanee Sawanyawisuth Chaisiri Wongkham Sopit Wongkham Khon Kaen University - Liver Fluke and Cholangiocarcinoma Research Center |
2012 | ||||
| 5. | Overexpression of O-GlcNAc-Transferase Associates with Aggressiveness of Mass-Forming Cholangiocarcinoma | Phoomak, C Silsirivanit, A Wongkham, C Sripa, B Puapairoj, A Wongkham, S |
2012 | ||||
| 6. | Serum alpha(1)beta-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma | Tolek, A Wongkham, C Proungvitaya, S Silsirivanit, A Roytrakul, S Khuntikeo, N Wongkham, S |
2012 | ||||
| 7. | Serum α |
Tolek, A. Wongkham, C. Proungvitaya, S. Silsirivanit, A. Khuntikeo, N. Wongkham, S. |
2012 | ||||
| 8. | State of serum markers for detection of cholangiocarcinoma. | Sopit Wongkham Atit Silsirivanit |
2012 | ||||
| 9. | TNP-470, A Methionine Aminopeptidase-2 Inhibitor, Inhibits Cell Proliferation, Migration and Invasion of Human Cholangiocarcinoma Cells In Vitro | Kidoikhammouan, S Seubwai, W Tantapotinan, N Silsirivanit, A Wongkham, S Sawanyawisuth, K Wongkham, C |
2012 | ||||
| 10. | Applications of Plant Lectins in Cholangiocarcinoma | Somsiri Indramanee Atit Silsirivanit Chawalit Pairojkul Chaisiri Wongkham Sopit Wongkham |
2013 | ||||
| 11. | CA-S27: A novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma | Silsirivanit, A Araki, N Wongkham, C Vaeteewoottacharn, K Pairojkul, C Kuwahara, K Narimatsu, Y Sawaki, H Narimatsu, H Okada, S Sakaguchi, N Wongkham, S |
2013 | ||||
| 12. | Comparison of microRNA (MiRNA) expression profiles between opisthorchis viverrini-associated cholangiocarcinoma (OV-CCA) and non-opisthorchis viverrini-associated cholangiocarcinoma (non-OV CCA) | Suebpong Tanasanvimon Asif Rashid Sopit Wongkham Chaitanya Churi Zhimin Tong David R. Fogelman Atit Silsirivanit Boris Blechacz Naruemon Klaikaew Vajarabhongsa Bhudhisawasdi Jean-Nicolas Vauthey Milind M. Javle |
2013 | ||||
| 13. | Sophora Japonica Agglutinin Reveals Aberrant Glycosylation in Cholangiocarcinoma | Waraporn Saentaweesuk Atit Silsirivanit Somsiri Indramanee Somchai Pinlaor Thidarut Boonmars Kulthida Vaeteewoottacharn Chaisiri Wongkham |
2013 | ||||
| 14. | Cancer biomarker discovery for cholangiocarcinoma: The high-throughput approaches | Atit Silsirivanit Kanlayanee Sawanyawisuth Gregory J. Riggins Chaisiri Wongkham |
2014 | ||||
| 15. | Tai Chi improves oxidative stress response and DNA damage/repair in young sedentary females | Xing-Yu Huang Wichai Eungpinichpong Atit Silsirivanit Saowanee Nakmareong Xiu-Hua Wu |
2014 | ||||
| 16. | A Promising Serum Autoantibody Marker, Anti-Heat Shock Protein 90α, for Cholangiocarcinoma. | Boonjaraspinyo, S. Juasook, A. Boonmars, T. Aukkanimart, R. Silsirivanit, A. Loilome, W. Sriraj, P. |
2015 | ||||
| 17. | Effects of GUASHA on Heart Rate Variability in Healthy Male Volunteers under Normal Condition and Weightlifters after Weightlifting Training Sessions. | Wang, X. Chatchawan, U. Nakmareong, S. Silsirivanit, A. Wang, Y. Xie, D. Eungpinichpong, W. |
2015 | ||||
| 18. | Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach. | Pattanapairoj, S. Silsirivanit, A. Muisuk, K. Seubwai, W. Cha'on, U. Vaeteewoottacharn, K. Sawanyawisuth, K. Chetchotsak, D. Wongkham, S. |
2015 | ||||
| 19. | Novel mutations in cholangiocarcinoma with low frequencies revealed by whole mitochondrial genome sequencing | Muisuk, K Silsirivanit, A Imtawil, K Bunthot, S Pukhem, A Pairojkul, C Wongkham, S Wongkham, C |
2015 | ||||
| 20. | Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB | Chatchai Phoomak Kulthida Vaeteewoottacharn Kanlayanee Sawanyawisuth Wunchana Seubwai Chaisiri Wongkham Atit Silsirivanit Sopit Wongkham |
2016 | ||||
| 21. | YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma | Silsirivanit, A. Wongkham, S. Talabnin, C. |
2016 | ||||
| 22. | Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis. | Saentaweesuk, W Silsirivanit, A Vaeteewoottacharn, K Sawanyawisuth, K Pairojkul, C Cha'on, U Indramanee, S Pinlaor, S Boonmars, T Araki, N Wongkham, C |
2017 | ||||
| 23. | High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation | Phoomak, C Vaeteewoottacharn, K Silsirivanit, A Saengboonmee, C Seubwai, W Sawanyawisuth, K Wongkham, C Wongkham, S |
2017 | ||||
| 24. | Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells | Vaeteewoottacharn, K. Silsirivanit, A. Seubwai, W. Talabnin, C. Muisuk, K. Sripa, B. Wongkham, S. Okada, S. Wongkham, C. |
2018 | ||||
| 25. | Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis | Silsirivanit, A. Vaeteewoottacharn, K. Sawanyawisuth, K. Pairojkul, C. Cha'on, U. Pinlaor, S. Boonmars, T. Wongkham, C. |
2018 | ||||
| 26. | GaINAcylated glycans specific to Sophora japonica agglun in-Values for diagnosis and prognosis of cholangiocarcinoma | Kanlayanee Sawanyawisuth Waraporn Saentaweesuk Atit Silsirivanit Kulthida Vaeteewoottacharn Chawalit Pairojkul Ubon Cha-on Somsiri Indramanee Somchai Pinlaor Thidarut Boonmars Sopit Wongkham Chaisiri Wongkham |
2018 | ||||
| 27. | Heterogeneity of E-cadherin and vimentin expressing cells is essential for highly metastatic cholangiocarcinoma cells | Waraporn Saentaweesuk Norie Araki Atit Silsirivanit Kulthida Vaeteewoottacharn Sopit Wongkham Chaisiri Wongkham |
2018 | ||||
| 28. | Isocitrate dehydrogenase gene mutations and 2-hydroxyglutarate accumulation in esophageal squamous cell carcinoma. | Miyake, K Baba, Y Ishimoto, T Hiyoshi, Y Iwatsuki, M Miyamoto, Y Yoshida, N Watanabe, M Ogata, Y Nagayama, M Silsirivanit, A Kobayashi, D Araki, N Baba, H |
2018 | ||||
| 29. | Neutrophil to Lymphocyte Ratio as a diagnostic and prognostic marker for cholangiocarcinoma | Atit Silsirivanit Siriporn Tangwiboonpanich Waraporn Saentaweesuk Samrit Kamapatte Danaipong Chetchotesak Sopit Wongkham Chaisiri Wongkham |
2018 | ||||
| 30. | New evidence of connections between increased O-GlcNAcylation and inflammasome in the oral mucosa of patients with oral lichen planus. | T. Thi Do C. Phoomak V. Champattanachai A. Silsirivanit P. Chaiyarit |
2018 | ||||
| 31. | O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1 | Chatchai Phoomak Atit Silsirivanit Dayoung Park Kanlayanee Sawanyawisuth Kulthida Vaeteewoottacharn Chaisiri Wongkham Eric W. -F. Lam Chawalit Pairojkul Carlito B. Lebrilla Sopit Wongkham |
2018 | ||||
| 32. | O-GlcNAcylation promotes metastasis of cholangiocarcinoma cells via suppression of FOXO3 expression | Chatchai Phoomak Atit Silsirivanit Kanlayanee Sawanyawisuth Kulthida Vaeteewoottacharn Chaisiri Wongkham Sopit Wongkham |
2018 | ||||
| 33. | Polypeptide N-acetylgalactosaminyltransferase 5 regulates growth and metastasis of cholangiocarcinoma | Marutpong Detarya Sriwipa Chuangchaiya Lukkana Sukprasert Atit Silsirivanit Kanlayanee Sawanyawisuth Sopit Wongkham Chaisiri Wongkham |
2018 | ||||
| 34. | Studies of key signals related to the maintenance and differentiation of glioma initiating cells by integrated-omics | Norie Araki Akiko N. Nambu Atit Silsirivanit Hiroki Okanishi Daiki Kobayashi Takuichiro Hide Hideo Nakamura |
2018 | ||||
| 35. | Blocking of methionine aminopeptidase-2 by TNP-470 induces apoptosis and increases chemosensitivity of cholangiocarcinoma | Kidoikhammouan, S. Seubwai, W. Silsirivanit, A. Wongkham, S. Sawanyawisuth, K. Wongkham, C. |
2019 | ||||
| 36. | Dependency of Cholangiocarcinoma on Cyclin D-Dependent Kinase Activity | Sittithumcharee, G Suppramote, O Vaeteewoottacharn, K Sirisuksakun, C Jamnongsong, S Laphanuwat, P Suntiparpluacha, M Matha, A Chusorn, P Buraphat, P Kakanaporn, C Charngkaew, K Silsirivanit, A Korphaisarn, K Limsrichamrern, S Tripatara, P Pairojkul, C Wongkham, S Sampattavanich, S Okada, S Jirawatnotai, S |
2019 | ||||
| 37. | Dependency of Cholangiocarcinoma on Cyclin D–Dependent Kinase Activity | Vaeteewoottacharn, K. Laphanuwat , Chusorn, P. Charngkaew, K. Silsirivanit, A. Pairojkul, C. Wongkham, S. Okada, S. |
2019 | ||||
| 38. | Establishment of highly transplantable cholangiocarcinoma cell lines from a patient-derived xenograft mouse model | Kulthida Vaeteewoottacharn Chawalit Pairojkul Ryusho Kariya Kanha Muisuk Kanokwan Imtawil Yaovalux Chamgramol Vajarabhongsa Bhudhisawasdi Narong Khuntikeo Ake Pugkhem O-Tur Saeseow Atit Silsirivanit Chaisiri Wongkham Sopit Wongkham Seiji Okada |
2019 | ||||
| 39. | Glycosylation markers in cancer | Silsirivanit, A | 2019 | ||||
| 40. | Increase of mal-ii binding alpha2,3-sialylated glycan is associated with 5-fu resistance and short survival of cholangiocarcinoma patients | Sasiprapa Wattanavises Atit Silsirivanit Kanlayanee Sawanyawisuth Ubon Cha'on Sakda Waraasawapati Waraporn Saentaweesuk Sukanya Luang Chalongchai Chalermwat Chaisiri Wongkham Sopit Wongkham |
2019 | ||||
| 41. | Isocitrate dehydrogenase gene mutations and 2-hydroxyglutarate accumulation in esophageal squamous cell carcinoma | Keisuke Miyake Yoshifumi Baba Takatsugu Ishimoto Yukiharu Hiyoshi Masaaki Iwatsuki Yuji Miyamoto Naoya Yoshida Masayuki Watanabe Yoko Ogata Megumi Nagayama Atit Silsirivanit Daiki Kobayashi Norie Araki Hideo Baba |
2019 | ||||
| 42. | Monosodium Glutamate (MSG) Renders Alkalinizing Properties and Its Urinary Metabolic Markers of MSG Consumption in Rats | Phetcharaburanin, J. Wongkham, C. Thanan, R. Silsirivanit, A. Anutrakulchai, Chaon, U. |
2019 | ||||
| 43. | O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma | Phoomak, C Park, D Silsirivanit, A Sawanyawisuth, K Vaeteewoottacharn, K Detarya, M Wongkham, C Lebrilla, CB Wongkham, S |
2019 | ||||
| 44. | Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients. | Atit Silsirivanit Chatchai Phoomak Karuntarat Teeravirote Sasiprapa Wattanavises Wunchana Seubwai Charupong Saengboonmee Zhaoqi Zhan Jin-ichi Inokuchi Akemi Suzuki Sopit Wongkham |
2019 | ||||
| 45. | Predictive utility of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intraductal papillary neoplasm of the bile duct | Kamsa-Ard, S. Pugkhem, A. Luvira, V. Titapun, A. Silsirivanit, A. Wongkham, S. Khuntikeo, N. Pairojkul, C. Bhudhisawasdi, V. |
2019 | ||||
| 46. | Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Wongkham, S. Wongkham, C. Silsirivanit, A. Somintara, O. Patrakitkomjorn, S. |
2019 | ||||
| 47. | Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway. | Sawanyawisuth, K. Silsirivanit, A. Phoomak, C. Wongkham, C. Okada, S. Wongkham, S. |
2019 | ||||
| 48. | Carbohydrate Antigen 50: Values for Diagnosis and Prognostic Prediction of Intrahepatic Cholangiocarcinoma | Silsirivanit, A. | 2020 | ||||
| 49. | Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient | Sripa, B Seubwai, W Vaeteewoottacharn, K Sawanyawisuth, K Silsirivanit, A Kaewkong, W Muisuk, K Dana, P Phoomak, C Lert-Itthiporn, W Luvira, V Pairojkul, C Teh, BT Wongkham, S Okada, S Chamgramol, Y |
2020 | ||||
| 50. | Glycans: potential therapeutic targets for cholangiocarcinoma and their therapeutic and diagnostic implications. | Silsirivanit, A | 2020 | ||||
| 51. | Kidney and urinary metabolic profiles of monosodium glutamate consumption in Wistar rats | Kanokwan Nahok Raynoo Thanan Atit Silsirivanit Carlo Selmi Ubon Cha'on |
2020 | ||||
| 52. | Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma | Silsirivanit, A Matsuda, A Kuno, A Tsuruno, C Uenoyama, Y Seubwai, W Angata, K Teeravirote, K Wongkham, C Araki, N Takahama, Y Wongkham, S Narimatsu, H |
2020 | ||||
| 53. | The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling. | Marutpong Detarya Kanlayanee Sawanyawisuth Chaiwat Aphivatanasiri Sriwipa Chuangchaiya Paksiree Saranaruk Lukkana Sukprasert Atit Silsirivanit Norie Araki Sopit Wongkham Chaisiri Wongkham |
2020 | ||||
| 54. | A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Butea monosperma Agglutinin | Luang, S. Waraasawapati, S. Boonsiri, P. Wongkham, C. Wongkham, S. Silsirivanit, A. |
2021 | ||||
| 55. | Antioxidant and Cytotoxic Activity of Phellinus Mushrooms from Northeast Thailand | Sonesay Thammavong Methin Phadungkit Pornpun Laoyachirasuwan Khwanyuruan Naksuwanku Waraporn Saentaweesuk Atit Silsirivanit Sopit Wongkham |
2021 | ||||
| 56. | Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma | Lert-Itthiporn, W. Silsirivanit, A. Okada, S. Wongkham, S. Seubwai, W. |
2021 | ||||
| 57. | Cyclin A is upregulated by high glucose and a potential target for cholangiocarcinoma patients with diabetes mellitus | Charupong Saengboonmee Wunchana Seubwai Sakkarn Sangkhamanon Marutpong Detarya Kanlayanee Sawanyawisuth Atit Silsirivanit Sopit Wongkham |
2021 | ||||
| 58. | Glycans: potential therapeutic targets for cholangiocarcinoma and their therapeutic and diagnostic implications | Atit Silsirivanit | 2021 | ||||
| 59. | Glycosylation in cholangiocarcinoma development and metastasis: Diagnostic and therapeutic considerations | Silsirivanit, A. Phoomak, C. Wongkham, S. |
2021 | ||||
| 60. | Monosodium Glutamate Induces Changes in Hepatic and Renal Metabolic Profiles and Gut Microbiome of Wistar Rats | Nahok, K. Phetcharaburanin, J. Silsirivanit, A. Thanan, R. Boonnate, P. Anutrakulchai, S. Chaon, U. |
2021 | ||||
| 61. | Targeting alpha2,3-sialylated glycan in glioma stem-like cells by Maackia amurensis lectin-II: A promising strategy for glioma treatment. | Putthisen, S Silsirivanit, A Panawan, O Niibori-Nambu, A Nishiyama-Ikeda, Y Main, P Luang, S Ohta, K Muisuk, K Wongkham, S Araki, N |
2021 | ||||
| 62. | Anserine/Carnosine-Rich Extract from Thai Native Chicken Suppresses Melanogenesis via Activation of ERK Signaling Pathway | Teeravirote, K. Sutthanut, K. Thonsri, U. Mahalapbutr, P. Seubwai, W. Luang, S. Tippayawat, P. Kanthawong, S. Pipattanaboon, C. Duangjinda, M. Chankitisakul, V. Silsirivanit, A. |
2022 | ||||
| 63. | Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways | Talabnin, C. Dechsukhum, C. Silsirivanit, A. Talabnin, K. |
2022 | ||||
| 64. | Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: a mechanistic insight. | Detarya, M Lert-Itthiporn, W Mahalapbutr, P Klaewkla, M Sorin, S Sawanyawisuth, K Silsirivanit, A Seubwai, W Wongkham, C Araki, N Wongkham, S |
2022 | ||||
| 65. | High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma. | Lertpanprom, M. | 2022 | ||||
| 66. | Inclusion complexation of emodin with various β-cyclodextrin derivatives: Preparation, characterization, molecular docking, and anticancer activity | Oo, A. Mahalapbutr, P. Krusong, K. Liangsakul, P. Thanasansurapong, S. Reutrakul, V. Kuhakarn, C. Maitarad, P. Silsirivanit, A. Wolschann, P. Putthisen, S. Kerdpol, K. Rungrotmongkol, T. |
2022 | ||||
| 67. | Monosodium glutamate consumption reduces the renal excretion of trimethylamine N-oxide and the abundance of Akkermansia muciniphila in the gut | Kyaw, TS Sukmak, M Nahok, K Sharma, A Silsirivanit, A Lert-Itthiporn, W Sansurin, N Senthong, V Anutrakulchai, S Sangkhamanon, S Pinlaor, S Selmi, C Hammock, BD Cha'on, U |
2022 | ||||
| 68. | Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells | Aung, TM Silsirivanit, A Jusakul, A Chan-On, W Proungvitaya, T Roytrakul, S Proungvitaya, S |
2022 | ||||
| 69. | Reply to Chao et al. Comment on “Nahok et al. Monosodium Glutamate Induces Changes in Hepatic and Renal Metabolic Profiles and Gut Microbiome of Wistar Rats. Nutrients 2021, 13, 1865” | Nahok, K. Phetcharaburanin, J. Silsirivanit, A. Thanan, R. Sharma, A. Anutrakulchai, S. Cha’on, U. |
2022 | ||||
| 70. | Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma. | Kimawaha, P. Thanan, R. Jusakul, A. Jamnongkan, W. Silsirivanit, A. Titapun, A. Khuntikeo, N. Sithithaworn, P. Worasith, C. Techasen, A. |
2022 | ||||
| 71. | Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients | Aung, TM Ciin, MN Silsirivanit, A Jusakul, A Lert-Itthiporn, W Proungvitaya, T Roytrakul, S Proungvitaya, S |
2022 | ||||
| 72. | Targeting alpha2,3-sialylated glycan in glioma stem-like cells by Maackia amurensis lectin-II: A promising strategy for glioma treatment | Silsirivanit, A. Luang, S. Muisuk, K. Wongkham, S. |
2022 | ||||
| 73. | Corrigendum to "Diminishing acetyl-CoA carboxylase 1 attenuates CCA migration via AMPK-NF-κB-snail axis" [Biochim. Biophys. Acta Mol. Basis Dis. 1869 (5) (2023) 166694 (PMID: 36972768)]. | Saisomboon, S Kariya, R Boonnate, P Sawanyawisuth, K Cha'on, U Luvira, V Chamgramol, Y Pairojkul, C Seubwai, W Silsirivanit, A Wongkham, S Okada, S Jitrapakdee, S Vaeteewoottacharn, K |
2023 | ||||
| 74. | Diminishing acetyl-CoA carboxylase 1 attenuates CCA migration via AMPK-NF-κB-snail axis | Saisomboon, S Kariya, R Boonnate, P Sawanyawisuth, K Cha'on, U Luvira, V Chamgramol, Y Pairojkul, C Seubwai, W Silsirivanit, A Wongkham, S Okada, S Jitrapakdee, S Vaeteewoottacharn, K |
2023 | ||||
| 75. | Discovery of amphotericin B, an antifungal drug as tyrosinase inhibitor with potent anti-melanogenic activity. | Mahalapbutr, P Sabuakham, S Nasoontorn, S Rungrotmongkol, T Silsirivanit, A Suriya, U |
2023 | ||||
| 76. | Establishment and characterization of a novel cancer stem-like cell of cholangiocarcinoma. | Panawan, O Silsirivanit, A Chang, CH Putthisen, S Boonnate, P Yokota, T Nishisyama-Ikeda, Y Detarya, M Sawanyawisuth, K Kaewkong, W Muisuk, K Luang, S Vaeteewoottacharn, K Kariya, R Yano, H Komohara, Y Ohta, K Okada, S Wongkham, S Araki, N |
2023 | ||||
| 77. | High Level of Serum Coiled-coil Domain Containing 25 (CCDC25) as a Diagnostic Marker for Cholangiocarcinoma But Not for Other Cancers | Jannawan, A Silsirivanit, A Seubwai, W Wongwattanakul, M Proungvitaya, T Aung, TM Roytrakul, S Chiawiriyabunya, I Proungvitaya, S |
2023 | ||||
| 78. | Mass Spectrometry of Neutral Glycosphingolipids | Suzuki, A Silsirivanit, A Watanabe, T Matsuda, J Inamori, KI Inokuchi, JI |
2023 | ||||
| 79. | Altered O-linked glycosylation in benign and malignant meningiomas. | Talabnin, C. Trasaktaweesakul, T. Jaturutthaweechot, P. Asavaritikrai, P. Kongnawakun, D. Silsirivanit, A. Araki, N. Talabnin, K. |
2024 | ||||
| 80. | Anilino-1,4-naphthoquinones as potent mushroom tyrosinase inhibitors: and studies. | Sabuakham, S Nasoontorn, S Kongtaworn, N Rungrotmongkol, T Silsirivanit, A Pingaew, R Mahalapbutr, P |
2024 | ||||
| 81. | Chondroitin sulfate modification of CSPG4 regulates the maintenance and differentiation of glioma-initiating cells via integrin-associated signaling. | Niibori-Nambu, A Yamasaki, Y Kobayashi, D Angata, K Kuno, A Panawan, O Silsirivanit, A Narimatsu, H Araki, N |
2024 | ||||
| 82. | Role of Wisteria floribunda agglutinin binding glycans in carcinogenesis and metastasis of cholangiocarcinoma. | Phuyathip, W Putthisen, S Panawan, O Ma-In, P Teeravirote, K Sintusen, P Udomkitkosol, S Detarya, M Luang, S Mahalapbutr, P Sato, T Kuno, A Chuangchaiya, S Silsirivanit, A |
2024 | ||||
| 83. | SRPK Inhibitors Reduce the Phosphorylation and Translocation of SR Protein Splicing Factors, thereby Correcting BIN1, MCL-1 and BCL2 Splicing Errors and Enabling Apoptosis of Cholangiocarcinoma Cells | Changphasuk, P. Inpad, C. Horpaopan, S. Khunchai, S. Phimsen, S. Surangkul, D. Janvilisri, T. Silsirivanit, A. Kaewkong, W. |
2024 | ||||
| 84. | Urinary metabolic profile and its predictive indexes after MSG consumption in rat. | Sukmak, M Kyaw, TS Nahok, K Sharma, A Silsirivanit, A Lert-Itthiporn, W Japrung, D Pinlaor, S Anutrakulchai, S Selmi, C Slupsky, CM Hammock, BD Cha'on, U |
2024 | ||||
| 85. | Cancer stem cells in cholangiocarcinoma: emerging roles as therapeutic targets | Panawan, O. Silsirivanit, A. Araki, N. |
2025 | ||||
| 86. | Clinical impacts of Artocarpus lakoocha agglutinin-binding glycans for prognosis and treatment of cholangiocarcinoma. | Sintusen, P Vaeteewoottacharn, K Cha'on, U Pairojkul, C Aphivatanasiri, C Suttiprapa, S Mahalapbutr, P Silsirivanit, A Wongkham, S Luang, S |
2025 | ||||
| 87. | Discovery of bis-thiourea derivatives as potent tyrosinase inhibitors: combined experimental and computational study | Sabuakham, S. Nasoontorn, S. Nuramrum, N. Silsirivanit, A. |
2025 | ||||
| 88. | Discovery of -thiourea derivatives as potent tyrosinase inhibitors: combined experimental and computational study. | Sabuakham, S Nasoontorn, S Nuramrum, N Silsirivanit, A Rungrotmongkol, T Pingaew, R Mahalapbutr, P |
2025 | ||||
| 89. | Exploring Kidney Injury Molecule-1 and HAVCR1 Polymorphisms as Predictive Biomarkers in Chronic Kidney Disease. | Chaiyagot, N Silsirivanit, A Cha'on, U Jusakul, A Techasen, A Nahok, K Chamdam, A Anutrakulchai, S Lert-Itthiporn, W |
2025 | ||||
| 90. | Integration of RNAseq transcriptomics and -glycomics reveal biosynthetic pathways and predict structure-specific -glycan expression. | Alvarez, MRS Holmes, XA Oloumi, A Grijaldo-Alvarez, SJ Schindler, R Zhou, Q Yadlapati, A Silsirivanit, A Lebrilla, CB |
2025 | ||||
| 91. | Integration of RNAseq transcriptomics and N-glycomics reveal biosynthetic pathways and predict structure-specific N-glycan expression | Alvarez, M.R.S. Holmes, X.A. Oloumi, A. Grijaldo-Alvarez, S.J. Schindler, R. Zhou, Q. Yadlapati, A. Silsirivanit, A. |
2025 | ||||
| 92. | Serum N-Glycomics with Nano-LC-QToF LC-MS/MS Reveals N-Glycan Biomarkers for Glioblastoma, Meningioma, and High-Grade Meningioma. | Silsirivanit, A. Alvarez, M.R.S. Grijaldo-Alvarez, S.J. Gogte, R. Kitkhuandee, A. Piyawattanametha, N. Seubwai, W. Luang, S. Panawan, O. Mahalapbutr, P. Vaeteewoottacharn, K. Sawanyawisuth, K. Let-Itthiporn, W. Saengboonmee, C. Duangthongphon, P. Jingjit, K. Pankongsap, A. Waraasawapati, S. Aphivatanasiri, C. Lebrilla, C.B. |
2025 | ||||
| 93. | Silencing of O-GlcNAc transferase attenuated O-GlcNAcylation and metastatic potentials of melanoma cells through suppression of Akt-NFkB signaling pathway. | Kanchanangkul, N Panawan, O Teeravirote, K Ma-In, P Mahalapbutr, P Luang, S Seubwai, W Lert-Itthiporn, W Kaewkong, W Vaeteewoottacharn, K Wongkham, S Roytrakul, S Silsirivanit, A |
2025 | ||||
| 94. | Soyasaponin-I Attenuates Melanogenesis through Activation of ERK and Suppression of PKA/CREB Signaling Pathways. | Ma-In, P Teeravirote, K Mahalapbutr, P Panawan, O Luang, S Silsirivanit, A |
2025 | Count | 61 | 58 | 48 | 3 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | A novel serum carbohydrate marker on mucin 5AC: Values for diagnostic and prognostic indicators for cholangiocarcinoma | Silsirivanit, A. Wongkham, C. Pairojkul, C. Wongkham, S. |
2011 |
Cancer 15 (117), pp. 3393-3403 |
||||||||
| 2. | Aberrant glycosylation in cholangiocarcinoma demonstrated by lectin-histochemistry | Silsirivanit, A. Pairojkul, C. Wongkham, C. Wongkham, S. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 119-124 |
||||||||
| 3. | A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: A potential marker for early diagnosis | Sawanyawisuth, K. Silsirivanit, A. Kunlabut, K. Tantapotinan, N. Vaeteewoottacharn, K. Wongkham, S. |
2012 |
Parasitology International 1 (61), pp. 151-154 |
||||||||
| 4. | Overexpression of O-GlcNAc-Transferase Associates with Aggressiveness of Mass-Forming Cholangiocarcinoma | Phoomak, C. Silsirivanit, A. Wongkham, C. Sripa, B. Puapairoj, A. Wongkham, S. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 101-105 |
||||||||
| 5. | Serum α<inf>1</inf>β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma | Tolek, A. Wongkham, C. Proungvitaya, S. Silsirivanit, A. Khuntikeo, N. Wongkham, S. |
2012 |
Experimental Biology and Medicine 10 (237), pp. 1142-1149 |
||||||||
| 6. | State of Serum Markers for Detection of Cholangiocarcinoma | Wongkham, S. Silsirivanit, A. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 17-27 |
||||||||
| 7. | TNP-470, A Methionine Aminopeptidase-2 Inhibitor, Inhibits Cell Proliferation, Migration and Invasion of Human Cholangiocarcinoma Cells In Vitro | Kidoikhammouan, S. Seubwai, W. Tantapotinan, N. Silsirivanit, A. Wongkham, S. Sawanyawisuth, K. Wongkham, C. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 155-160 |
||||||||
| 8. | CA-S27: A novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma | Silsirivanit, A. Wongkham, C. Vaeteewoottacharn, K. Pairojkul, C. Okada, S. Wongkham, S. |
2013 |
Cancer Science 10 (104), pp. 1278-1284 |
||||||||
| 9. | Cancer biomarker discovery for cholangiocarcinoma: The high-throughput approaches | Silsirivanit, A. Sawanyawisuth, K. Wongkham, C. |
2014 |
Journal of Hepato-Biliary-Pancreatic Sciences 6 (21), pp. 388-396 |
||||||||
| 10. | Tai Chi improves oxidative stress response and DNA damage/repair in young sedentary females | Huang, X. Eungpinichpong, W. Silsirivanit, A. Nakmareong, S. |
2014 |
Journal of Physical Therapy Science 6 (26), pp. 825-829 |
||||||||
| 11. | A promising serum autoantibody marker, anti-heat shock protein 90α, for cholangiocarcinoma | Boonjaraspinyo, S. Juasook, A. Boonmars, T. Aukkanimart, R. Silsirivanit, A. Loilome, W. Sriraj, P. |
2015 |
Asian Pacific Journal of Cancer Prevention 14 (16), pp. 5779-5785 |
||||||||
| 12. | Effects of GUASHA on Heart Rate Variability in Healthy Male Volunteers under Normal Condition and Weightlifters after Weightlifting Training Sessions | Wang, X. Chatchawan, U. Nakmareong, S. Silsirivanit, A. Wang, Y. Xie, D. Eungpinichpong, W. |
2015 |
Evidence-based Complementary and Alternative Medicine (2015), pp. |
||||||||
| 13. | Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach | Pattanapairoj, S. Silsirivanit, A. Muisuk, K. Seubwai, W. Cha'on, U. Vaeteewoottacharn, K. Sawanyawisuth, K. Chetchotsak, D. Wongkham, S. |
2015 |
Clinical Biochemistry 10-11 (48), pp. 668-673 |
||||||||
| 14. | Novel mutations in cholangiocarcinoma with low frequencies revealed by whole mitochondrial genome sequencing | Muisuk, K. Silsirivanit, A. Imtawil, K.J. Bunthot, S. Pukhem, A. Pairojkul, C. Wongkham, S. Wongkham, C. |
2015 |
Asian Pacific Journal of Cancer Prevention 5 (16), pp. 1737-1742 |
||||||||
| 15. | Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB | Phoomak, C. Vaeteewoottacharn, K. Sawanyawisuth, K. Seubwai, W. Wongkham, C. Silsirivanit, A. Wongkham, S. |
2016 |
Scientific Reports (6), pp. |
||||||||
| 16. | YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma | Silsirivanit, A. Wongkham, S. Talabnin, C. |
2016 |
Tumor Biology 7 (37), pp. 9451-9463 |
||||||||
| 17. | High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation | Phoomak, C. Vaeteewoottacharn, K. Silsirivanit, A. Saengboonmee, C. Seubwai, W. Sawanyawisuth, K. Wongkham, C. |
2017 |
Scientific Reports (7), pp. |
||||||||
| 18. | Activation of vimentin is critical to promote a metastatic potential of cholangiocarcinoma cells | Vaeteewoottacharn, K. Silsirivanit, A. Seubwai, W. Talabnin, C. Muisuk, K. Sripa, B. Wongkham, S. Okada, S. Wongkham, C. |
2018 |
Oncology Research 4 (26), pp. 605-616 |
||||||||
| 19. | Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis | Silsirivanit, A. Vaeteewoottacharn, K. Sawanyawisuth, K. Pairojkul, C. Cha'on, U. Pinlaor, S. Boonmars, T. Wongkham, C. |
2018 |
Clinica Chimica Acta (477), pp. 66-71 |
||||||||
| 20. | New evidence of connections between increased O-GlcNAcylation and inflammasome in the oral mucosa of patients with oral lichen planus | Phoomak, C. Silsirivanit, A. Chaiyarit, P. |
2018 |
Clinical and Experimental Immunology 1 (192), pp. 129-137 |
||||||||
| 21. | O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1 | Phoomak, C. Silsirivanit, A. Sawanyawisuth, K. Vaeteewoottacharn, K. Wongkham, C. Pairojkul, C. Wongkham, S. |
2018 |
Oncogene 42 (37), pp. 5648-5665 |
||||||||
| 22. | Blocking of methionine aminopeptidase-2 by TNP-470 induces apoptosis and increases chemosensitivity of cholangiocarcinoma | Kidoikhammouan, S. Seubwai, W. Silsirivanit, A. Wongkham, S. Sawanyawisuth, K. Wongkham, C. |
2019 |
Journal of Cancer Research and Therapeutics 1 (15), pp. 148-152 |
||||||||
| 23. | Dependency of Cholangiocarcinoma on Cyclin D–Dependent Kinase Activity | Vaeteewoottacharn, K. Laphanuwat , Chusorn, P. Charngkaew, K. Silsirivanit, A. Pairojkul, C. Wongkham, S. Okada, S. |
2019 |
Hepatology 5 (70), pp. 1614-1630 |
||||||||
| 24. | Establishment of highly transplantable cholangiocarcinoma cell lines from a patient-derived xenograft mouse model | Vaeteewoottacharn, K. Pairojkul, C. Muisuk, K. Imtawil, K. Chamgramol, Y. Bhudhisawasdi, V. Khuntikeo, N. Pugkhem, A. Saeseow, O.T. Silsirivanit, A. Wongkham, C. Wongkham, S. Okada, S. |
2019 |
Cells 5 (8), pp. |
||||||||
| 25. | Glycosylation markers in cancer | Silsirivanit, A. | 2019 |
Advances in Clinical Chemistry (89), pp. 189-213 |
||||||||
| 26. | Increase of mal-ii binding alpha2,3-sialylated glycan is associated with 5-fu resistance and short survival of cholangiocarcinoma patients | Silsirivanit, A. Sawanyawisuth, K. Chaon, U. Waraasawapati, S. Wongkham, C. Wongkham, S. |
2019 |
Medicina (Lithuania) 12 (55), pp. |
||||||||
| 27. | Isocitrate dehydrogenase gene mutations and 2-hydroxyglutarate accumulation in esophageal squamous cell carcinoma | Miyake, K. Baba, Y. Ishimoto, T. Silsirivanit, A. Kobayashi, D. |
2019 |
Medical Oncology 1 (36), pp. |
||||||||
| 28. | Monosodium glutamate (MSG) renders alkalinizing properties and its urinary metabolic markers of MSG consumption in rats | Phetcharaburanin, J. Wongkham, C. Thanan, R. Silsirivanit, A. Anutrakulchai, Chaon, U. |
2019 |
Biomolecules 10 (9), pp. |
||||||||
| 29. | O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma | Phoomak, C. Silsirivanit, A. Sawanyawisuth, K. Vaeteewoottacharn, K. Wongkham, C. Wongkham, S. |
2019 |
Molecular Oncology 2 (13), pp. 338-357 |
||||||||
| 30. | Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients | Silsirivanit, A. Phoomak, C. Seubwai, W. Saengboonmee, C. Wongkham, S. |
2019 |
Glycoconjugate Journal 2 (36), pp. 103-111 |
||||||||
| 31. | Predictive utility of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intraductal papillary neoplasm of the bile duct | Kamsa-Ard, S. Pugkhem, A. Luvira, V. Titapun, A. Silsirivanit, A. Wongkham, S. Khuntikeo, N. Pairojkul, C. Bhudhisawasdi, V. |
2019 |
Clinical and Experimental Hepatology 3 (5), pp. 250-255 |
||||||||
| 32. | Serum apurinic/apyrimidinic endodeoxyribonuclease 1 (APEX1) level as a potential biomarker of cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Wongkham, S. Wongkham, C. Silsirivanit, A. Somintara, O. Patrakitkomjorn, S. |
2019 |
Biomolecules 9 (9), pp. |
||||||||
| 33. | Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway | Sawanyawisuth, K. Silsirivanit, A. Phoomak, C. Wongkham, C. Okada, S. Wongkham, S. |
2019 |
Scientific Reports 1 (9), pp. |
||||||||
| 34. | Carbohydrate antigen 50: Values for diagnosis and prognostic prediction of intrahepatic cholangiocarcinoma | Silsirivanit, A. | 2020 |
Medicina (Lithuania) 11 (56), pp. 1-9 |
||||||||
| 35. | Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient | Sripa, B. Seubwai, W. Vaeteewoottacharn, K. Sawanyawisuth, K. Silsirivanit, A. Kaewkong, W. Muisuk, K. Phoomak, C. Lert-Itthiporn, W. Pairojkul, C. Wongkham, S. Okada, S. Chamgramol, Y. |
2020 |
Human Cell 3 (33), pp. 695-708 |
||||||||
| 36. | Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma | Silsirivanit, A. Seubwai, W. Wongkham, C. Wongkham, S. |
2020 |
Clinica Chimica Acta (510), pp. 142-149 |
||||||||
| 37. | The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling | Sawanyawisuth, K. Silsirivanit, A. Wongkham, S. Wongkham, C. |
2020 |
Glycobiology 5 (30), pp. 312-324 |
||||||||
| 38. | A novel serum glycobiomarker for diagnosis and prognosis of cholangiocarcinoma detected by Butea monosperma agglutinin | Luang, S. Waraasawapati, S. Boonsiri, P. Wongkham, C. Wongkham, S. Silsirivanit, A. |
2021 |
Molecules 9 (26), pp. |
||||||||
| 39. | Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma | Lert-Itthiporn, W. Silsirivanit, A. Okada, S. Wongkham, S. Seubwai, W. |
2021 |
PeerJ (9), pp. |
||||||||
| 40. | Glycans: potential therapeutic targets for cholangiocarcinoma and their therapeutic and diagnostic implications | Silsirivanit, A. | 2021 |
Expert Opinion on Therapeutic Targets 1 (25), pp. 1-4 |
||||||||
| 41. | Glycosylation in cholangiocarcinoma development and metastasis: Diagnostic and therapeutic considerations | Silsirivanit, A. Phoomak, C. Wongkham, S. |
2021 |
Diagnosis and Management of Cholangiocarcinoma: A Multidisciplinary Approach (), pp. 527-553 |
||||||||
| 42. | Monosodium glutamate induces changes in hepatic and renal metabolic profiles and gut microbiome of wistar rats | Nahok, K. Phetcharaburanin, J. Silsirivanit, A. Thanan, R. Boonnate, P. Anutrakulchai, S. Chaon, U. |
2021 |
Nutrients 6 (13), pp. |
||||||||
| 43. | Anserine/Carnosine-Rich Extract from Thai Native Chicken Suppresses Melanogenesis via Activation of ERK Signaling Pathway | Teeravirote, K. Sutthanut, K. Thonsri, U. Mahalapbutr, P. Seubwai, W. Luang, S. Tippayawat, P. Kanthawong, S. Pipattanaboon, C. Duangjinda, M. Chankitisakul, V. Silsirivanit, A. |
2022 |
Molecules 21 (27), pp. |
||||||||
| 44. | Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways | Talabnin, C. Dechsukhum, C. Silsirivanit, A. Talabnin, K. |
2022 |
Life 2 (12), pp. |
||||||||
| 45. | High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma | Lertpanprom, M. | 2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 46. | Inclusion complexation of emodin with various β-cyclodextrin derivatives: Preparation, characterization, molecular docking, and anticancer activity | Oo, A. Mahalapbutr, P. Krusong, K. Liangsakul, P. Thanasansurapong, S. Reutrakul, V. Kuhakarn, C. Maitarad, P. Silsirivanit, A. Wolschann, P. Putthisen, S. Kerdpol, K. Rungrotmongkol, T. |
2022 |
Journal of Molecular Liquids (367), pp. |
||||||||
| 47. | Monosodium glutamate consumption reduces the renal excretion of trimethylamine N-oxide and the abundance of Akkermansia muciniphila in the gut | Nahok, K. Sharma, A. Silsirivanit, A. Lert-Itthiporn, W. Sansurin, N. Senthong, V. Anutrakulchai, S. Sangkhamanon, S. Pinlaor, S. Cha’on, U. |
2022 |
Biochemical and Biophysical Research Communications (630), pp. 158-166 |
||||||||
| 48. | Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells | Aung, T.M. Silsirivanit, A. Jusakul, A. Chan-On, W. Proungvitaya, T. Roytrakul, S. Proungvitaya, S. |
2022 |
Cancer Genomics and Proteomics 4 (19), pp. 490-502 |
||||||||
| 49. | Reply to Chao et al. Comment on “Nahok et al. Monosodium Glutamate Induces Changes in Hepatic and Renal Metabolic Profiles and Gut Microbiome of Wistar Rats. Nutrients 2021, 13, 1865” | Nahok, K. Phetcharaburanin, J. Silsirivanit, A. Thanan, R. Sharma, A. Anutrakulchai, S. Cha’on, U. |
2022 |
Nutrients 20 (14), pp. |
||||||||
| 50. | Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma | Kimawaha, P. Thanan, R. Jusakul, A. Jamnongkan, W. Silsirivanit, A. Titapun, A. Khuntikeo, N. Sithithaworn, P. Worasith, C. Techasen, A. |
2022 |
Clinica Chimica Acta (536), pp. 142-154 |
||||||||
| 51. | Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients | Silsirivanit, A. Jusakul, A. Lert-Itthiporn, W. Proungvitaya, T. Patrakitkomjorn, S. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 52. | Targeting alpha2,3-sialylated glycan in glioma stem-like cells by Maackia amurensis lectin-II: A promising strategy for glioma treatment | Silsirivanit, A. Luang, S. Muisuk, K. Wongkham, S. |
2022 |
Experimental Cell Research 1 (410), pp. |
||||||||
| 53. | Diminishing acetyl-CoA carboxylase 1 attenuates CCA migration via AMPK-NF-κB-snail axis | Saisomboon, S. Kariya, R. Boonnate, P. Sawanyawisuth, K. Cha'on, U. Luvira, V. Chamgramol, Y. Pairojkul, C. Seubwai, W. Silsirivanit, A. Wongkham, S. Okada, S. Jitrapakdee, S. Vaeteewoottacharn, K. |
2023 |
Biochimica et Biophysica Acta - Molecular Basis of Disease 5 (1869), pp. |
||||||||
| 54. | High Level of Serum Coiled-coil Domain Containing 25 (CCDC25) as a Diagnostic Marker for Cholangiocarcinoma But Not for Other Cancers | Jannawan, A. | 2023 |
In Vivo 1 (37), pp. 294-303 |
||||||||
| 55. | Mass Spectrometry of Neutral Glycosphingolipids | Suzuki, A. Silsirivanit, A. Watanabe, T. Matsuda, J. Inamori, K.i. Inokuchi, J.i. |
2023 |
Methods in Molecular Biology (2613), pp. 127-144 |
||||||||
| 56. | Altered O-linked glycosylation in benign and malignant meningiomas | Talabnin, C. Trasaktaweesakul, T. Jaturutthaweechot, P. Asavaritikrai, P. Kongnawakun, D. Silsirivanit, A. Araki, N. Talabnin, K. |
2024 |
PeerJ (12), pp. |
||||||||
| 57. | SRPK Inhibitors Reduce the Phosphorylation and Translocation of SR Protein Splicing Factors, thereby Correcting BIN1, MCL-1 and BCL2 Splicing Errors and Enabling Apoptosis of Cholangiocarcinoma Cells | Changphasuk, P. Inpad, C. Horpaopan, S. Khunchai, S. Phimsen, S. Surangkul, D. Janvilisri, T. Silsirivanit, A. Kaewkong, W. |
2024 |
Frontiers in Bioscience - Scholar 3 (16), pp. |
||||||||
| 58. | Cancer stem cells in cholangiocarcinoma: emerging roles as therapeutic targets | Panawan, O. Silsirivanit, A. Araki, N. |
2025 |
Hepatoma Research (11), pp. |
||||||||
| 59. | Discovery of bis-thiourea derivatives as potent tyrosinase inhibitors: combined experimental and computational study | Sabuakham, S. Nasoontorn, S. Nuramrum, N. Silsirivanit, A. |
2025 |
Journal of Enzyme Inhibition and Medicinal Chemistry 1 (40), pp. |
||||||||
| 60. | Integration of RNAseq transcriptomics and N-glycomics reveal biosynthetic pathways and predict structure-specific N-glycan expression | Alvarez, M.R.S. Holmes, X.A. Oloumi, A. Grijaldo-Alvarez, S.J. Schindler, R. Zhou, Q. Yadlapati, A. Silsirivanit, A. |
2025 |
Chemical Science 17 (16), pp. 7155-7172 |
||||||||
| 61. | Serum N-Glycomics with Nano-LC-QToF LC-MS/MS Reveals N-Glycan Biomarkers for Glioblastoma, Meningioma, and High-Grade Meningioma | Silsirivanit, A. Alvarez, M.R.S. Grijaldo-Alvarez, S.J. Gogte, R. Kitkhuandee, A. Piyawattanametha, N. Seubwai, W. Luang, S. Panawan, O. Mahalapbutr, P. Vaeteewoottacharn, K. Sawanyawisuth, K. Let-Itthiporn, W. Saengboonmee, C. Duangthongphon, P. Jingjit, K. Pankongsap, A. Waraasawapati, S. Aphivatanasiri, C. Lebrilla, C.B. |
2025 |
Journal of Proteome Research 3 (24), pp. 1402-1413 |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | A novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma. | Silsirivanit, A Araki, N Wongkham, C Pairojkul, C Narimatsu, Y Kuwahara, K Narimatsu, H Wongkham, S Sakaguchi, N |
2011 |
Cancer 15 (117), pp. 3393-403 |
|
| 2. | Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma. | Tolek, A Wongkham, C Proungvitaya, S Silsirivanit, A Roytrakul, S Khuntikeo, N Wongkham, S |
2012 |
Experimental biology and medicine (Maywood, N.J.) 10 (237), pp. 1142-9 |
|
| 3. | State of serum markers for detection of cholangiocarcinoma. | Wongkham, S Silsirivanit, A |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 17-27 |
|
| 4. | TNP-470, a methionine aminopeptidase-2 inhibitor, inhibits cell proliferation, migration and invasion of human cholangiocarcinoma cells in vitro. | Kidoikhammouan, S Seubwai, W Tantapotinan, N Silsirivanit, A Wongkham, S Sawanyawisuth, K Wongkham, C |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 155-60 |
|
| 5. | Aberrant glycosylation in cholangiocarcinoma demonstrated by lectin-histochemistry. | Indramanee, S Silsirivanit, A Pairojkul, C Wongkham, C Wongkham, S |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 119-24 |
|
| 6. | Overexpression of O-GlcNAc-transferase associates with aggressiveness of mass-forming cholangiocarcinoma. | Phoomak, C Silsirivanit, A Wongkham, C Sripa, B Puapairoj, A Wongkham, S |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 101-5 |
|
| 7. | A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis. | Sawanyawisuth, K Silsirivanit, A Kunlabut, K Tantapotinan, N Vaeteewoottacharn, K Wongkham, S |
2012 |
Parasitology international 1 (61), pp. 151-4 |
|
| 8. | CA-S27: a novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma. | Silsirivanit, A Araki, N Wongkham, C Vaeteewoottacharn, K Pairojkul, C Kuwahara, K Narimatsu, Y Sawaki, H Narimatsu, H Okada, S Sakaguchi, N Wongkham, S |
2013 |
Cancer science 10 (104), pp. 1278-84 |
|
| 9. | Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches. | Silsirivanit, A Sawanyawisuth, K Riggins, GJ Wongkham, C |
2014 |
Journal of hepato-biliary-pancreatic sciences 6 (21), pp. 388-96 |
|
| 10. | Tai chi improves oxidative stress response and DNA damage/repair in young sedentary females. | Huang, XY Eungpinichpong, W Silsirivanit, A Nakmareong, S Wu, XH |
2014 |
Journal of physical therapy science 6 (26), pp. 825-9 |
|
| 11. | Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach. | Pattanapairoj, S Silsirivanit, A Muisuk, K Seubwai, W Cha'on, U Vaeteewoottacharn, K Sawanyawisuth, K Chetchotsak, D Wongkham, S |
2015 |
Clinical biochemistry 10 (48), pp. 668-73 |
|
| 12. | Novel mutations in cholangiocarcinoma with low frequencies revealed by whole mitochondrial genome sequencing. | Muisuk, K Silsirivanit, A Imtawil, K Bunthot, S Pukhem, A Pairojkul, C Wongkham, S Wongkham, C |
2015 |
Asian Pacific journal of cancer prevention : APJCP 5 (16), pp. 1737-42 |
|
| 13. | A Promising Serum Autoantibody Marker, Anti-Heat Shock Protein 90α, for Cholangiocarcinoma. | Boonjaraspinyo, S Juasook, A Boonmars, T Aukkanimart, R Silsirivanit, A Loilome, W Sriraj, P Wu, Z Ratanasuwan, P |
2015 |
Asian Pacific journal of cancer prevention : APJCP 14 (16), pp. 5779-85 |
|
| 14. | Effects of GUASHA on Heart Rate Variability in Healthy Male Volunteers under Normal Condition and Weightlifters after Weightlifting Training Sessions. | Wang, X Chatchawan, U Nakmareong, S Silsirivanit, A Wang, Y Xie, D Yang, J Eungpinichpong, W |
2015 |
Evidence-based complementary and alternative medicine : eCAM (2015), pp. 268471 |
|
| 15. | YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma. | Thongsom, S Chaocharoen, W Silsirivanit, A Wongkham, S Sripa, B Choe, H Suginta, W Talabnin, C |
2016 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 7 (37), pp. 9451-63 |
|
| 16. | Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB. | Phoomak, C Vaeteewoottacharn, K Sawanyawisuth, K Seubwai, W Wongkham, C Silsirivanit, A Wongkham, S |
2016 |
Scientific reports (6), pp. 27853 |
|
| 17. | Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis. | Saentaweesuk, W Silsirivanit, A Vaeteewoottacharn, K Sawanyawisuth, K Pairojkul, C Cha'on, U Indramanee, S Pinlaor, S Boonmars, T Araki, N Wongkham, C |
2017 |
Clinica chimica acta; international journal of clinical chemistry (477), pp. 66-71 |
|
| 18. | High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation. | Phoomak, C Vaeteewoottacharn, K Silsirivanit, A Saengboonmee, C Seubwai, W Sawanyawisuth, K Wongkham, C Wongkham, S |
2017 |
Scientific reports (7), pp. 43842 |
|
| 19. | Isocitrate dehydrogenase gene mutations and 2-hydroxyglutarate accumulation in esophageal squamous cell carcinoma. | Miyake, K Baba, Y Ishimoto, T Hiyoshi, Y Iwatsuki, M Miyamoto, Y Yoshida, N Watanabe, M Ogata, Y Nagayama, M Silsirivanit, A Kobayashi, D Araki, N Baba, H |
2018 |
Medical oncology (Northwood, London, England) 1 (36), pp. 11 |
|
| 20. | O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1. | Phoomak, C Silsirivanit, A Park, D Sawanyawisuth, K Vaeteewoottacharn, K Wongkham, C Lam, EW Pairojkul, C Lebrilla, CB Wongkham, S |
2018 |
Oncogene 42 (37), pp. 5648-5665 |
|
| 21. | New evidence of connections between increased O-GlcNAcylation and inflammasome in the oral mucosa of patients with oral lichen planus. | Thi Do, T Phoomak, C Champattanachai, V Silsirivanit, A Chaiyarit, P |
2018 |
Clinical and experimental immunology 1 (192), pp. 129-137 |
|
| 22. | Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells. | Saentaweesuk, W Araki, N Vaeteewoottacharn, K Silsirivanit, A Seubwai, W Talabnin, C Muisuk, K Sripa, B Wongkham, S Okada, S Wongkham, C |
2018 |
Oncology research 4 (26), pp. 605-616 |
|
| 23. | Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients. | Silsirivanit, A Phoomak, C Teeravirote, K Wattanavises, S Seubwai, W Saengboonmee, C Zhan, Z Inokuchi, JI Suzuki, A Wongkham, S |
2019 |
Glycoconjugate journal 2 (36), pp. 103-111 |
|
| 24. | Dependency of Cholangiocarcinoma on Cyclin D-Dependent Kinase Activity. | Sittithumcharee, G Suppramote, O Vaeteewoottacharn, K Sirisuksakun, C Jamnongsong, S Laphanuwat, P Suntiparpluacha, M Matha, A Chusorn, P Buraphat, P Kakanaporn, C Charngkaew, K Silsirivanit, A Korphaisarn, K Limsrichamrern, S Tripatara, P Pairojkul, C Wongkham, S Sampattavanich, S Okada, S Jirawatnotai, S |
2019 |
Hepatology (Baltimore, Md.) 5 (70), pp. 1614-1630 |
|
| 25. | Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway. | Indramanee, S Sawanyawisuth, K Silsirivanit, A Dana, P Phoomak, C Kariya, R Klinhom-On, N Sorin, S Wongkham, C Okada, S Wongkham, S |
2019 |
Scientific reports 1 (9), pp. 17266 |
|
| 26. | O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma. | Phoomak, C Park, D Silsirivanit, A Sawanyawisuth, K Vaeteewoottacharn, K Detarya, M Wongkham, C Lebrilla, CB Wongkham, S |
2019 |
Molecular oncology 2 (13), pp. 338-357 |
|
| 27. | Glycosylation markers in cancer. | Silsirivanit, A | 2019 |
Advances in clinical chemistry (89), pp. 189-213 |
|
| 28. | Blocking of methionine aminopeptidase-2 by TNP-470 induces apoptosis and increases chemosensitivity of cholangiocarcinoma. | Kidoikhammouan, S Seubwai, W Silsirivanit, A Wongkham, S Sawanyawisuth, K Wongkham, C |
2019 |
Journal of cancer research and therapeutics 1 (15), pp. 148-152 |
|
| 29. | Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient. | Sripa, B Seubwai, W Vaeteewoottacharn, K Sawanyawisuth, K Silsirivanit, A Kaewkong, W Muisuk, K Dana, P Phoomak, C Lert-Itthiporn, W Luvira, V Pairojkul, C Teh, BT Wongkham, S Okada, S Chamgramol, Y |
2020 |
Human cell 3 (33), pp. 695-708 |
|
| 30. | Glycans: potential therapeutic targets for cholangiocarcinoma and their therapeutic and diagnostic implications. | Silsirivanit, A | 2020 |
Expert opinion on therapeutic targets (), pp. 1-4 |
|
| 31. | The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling. | Detarya, M Sawanyawisuth, K Aphivatanasiri, C Chuangchaiya, S Saranaruk, P Sukprasert, L Silsirivanit, A Araki, N Wongkham, S Wongkham, C |
2020 |
Glycobiology 5 (30), pp. 312-324 |
|
| 32. | Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma. | Silsirivanit, A Matsuda, A Kuno, A Tsuruno, C Uenoyama, Y Seubwai, W Angata, K Teeravirote, K Wongkham, C Araki, N Takahama, Y Wongkham, S Narimatsu, H |
2020 |
Clinica chimica acta; international journal of clinical chemistry (510), pp. 142-149 |
|
| 33. | Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma. | Sungwan, P Lert-Itthiporn, W Silsirivanit, A Klinhom-On, N Okada, S Wongkham, S Seubwai, W |
2021 |
PeerJ (9), pp. e11067 |
|
| 34. | Targeting alpha2,3-sialylated glycan in glioma stem-like cells by Maackia amurensis lectin-II: A promising strategy for glioma treatment. | Putthisen, S Silsirivanit, A Panawan, O Niibori-Nambu, A Nishiyama-Ikeda, Y Main, P Luang, S Ohta, K Muisuk, K Wongkham, S Araki, N |
2021 |
Experimental cell research (), pp. 112949 |
|
| 35. | High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma. | Lertpanprom, M Silsirivanit, A Tippayawat, P Proungvitaya, T Roytrakul, S Proungvitaya, S |
2022 |
Frontiers in public health (10), pp. 835914 |
|
| 36. | Monosodium glutamate consumption reduces the renal excretion of trimethylamine N-oxide and the abundance of Akkermansia muciniphila in the gut. | Kyaw, TS Sukmak, M Nahok, K Sharma, A Silsirivanit, A Lert-Itthiporn, W Sansurin, N Senthong, V Anutrakulchai, S Sangkhamanon, S Pinlaor, S Selmi, C Hammock, BD Cha'on, U |
2022 |
Biochemical and biophysical research communications (630), pp. 158-166 |
|
| 37. | Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients. | Aung, TM Ciin, MN Silsirivanit, A Jusakul, A Lert-Itthiporn, W Proungvitaya, T Roytrakul, S Proungvitaya, S |
2022 |
Frontiers in public health (10), pp. 836985 |
|
| 38. | Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: a mechanistic insight. | Detarya, M Lert-Itthiporn, W Mahalapbutr, P Klaewkla, M Sorin, S Sawanyawisuth, K Silsirivanit, A Seubwai, W Wongkham, C Araki, N Wongkham, S |
2022 |
American journal of cancer research 9 (12), pp. 4140-4159 |
|
| 39. | Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma. | Kimawaha, P Thanan, R Jusakul, A Jamnongkan, W Silsirivanit, A Sa-Ngaimwibool, P Titapun, A Khuntikeo, N Sithithaworn, P Worasith, C Janthamala, S Lebrilla, CB Techasen, A |
2022 |
Clinica chimica acta; international journal of clinical chemistry (536), pp. 142-154 |
|
| 40. | Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells. | Aung, TM Silsirivanit, A Jusakul, A Chan-On, W Proungvitaya, T Roytrakul, S Proungvitaya, S |
2022 |
Cancer genomics & proteomics 4 (19), pp. 490-502 |
|
| 41. | High Level of Serum Coiled-coil Domain Containing 25 (CCDC25) as a Diagnostic Marker for Cholangiocarcinoma But Not for Other Cancers. | Jannawan, A Silsirivanit, A Seubwai, W Wongwattanakul, M Proungvitaya, T Aung, TM Roytrakul, S Chiawiriyabunya, I Proungvitaya, S |
2023 |
In vivo (Athens, Greece) 1 (37), pp. 294-303 |
|
| 42. | Mass Spectrometry of Neutral Glycosphingolipids. | Suzuki, A Silsirivanit, A Watanabe, T Matsuda, J Inamori, KI Inokuchi, JI |
2023 |
Methods in molecular biology (Clifton, N.J.) (2613), pp. 127-144 |
|
| 43. | Diminishing acetyl-CoA carboxylase 1 attenuates CCA migration via AMPK-NF-κB-snail axis. | Saisomboon, S Kariya, R Boonnate, P Sawanyawisuth, K Cha'on, U Luvira, V Chamgramol, Y Pairojkul, C Seubwai, W Silsirivanit, A Wongkham, S Okada, S Jitrapakdee, S Vaeteewoottacharn, K |
2023 |
Biochimica et biophysica acta. Molecular basis of disease (), pp. 166694 |
|
| 44. | Discovery of amphotericin B, an antifungal drug as tyrosinase inhibitor with potent anti-melanogenic activity. | Mahalapbutr, P Sabuakham, S Nasoontorn, S Rungrotmongkol, T Silsirivanit, A Suriya, U |
2023 |
International journal of biological macromolecules (246), pp. 125587 |
|
| 45. | Establishment and characterization of a novel cancer stem-like cell of cholangiocarcinoma. | Panawan, O Silsirivanit, A Chang, CH Putthisen, S Boonnate, P Yokota, T Nishisyama-Ikeda, Y Detarya, M Sawanyawisuth, K Kaewkong, W Muisuk, K Luang, S Vaeteewoottacharn, K Kariya, R Yano, H Komohara, Y Ohta, K Okada, S Wongkham, S Araki, N |
2023 |
Cancer science 8 (114), pp. 3230-3246 |
|
| 46. | Corrigendum to "Diminishing acetyl-CoA carboxylase 1 attenuates CCA migration via AMPK-NF-κB-snail axis" [Biochim. Biophys. Acta Mol. Basis Dis. 1869 (5) (2023) 166694 (PMID: 36972768)]. | Saisomboon, S Kariya, R Boonnate, P Sawanyawisuth, K Cha'on, U Luvira, V Chamgramol, Y Pairojkul, C Seubwai, W Silsirivanit, A Wongkham, S Okada, S Jitrapakdee, S Vaeteewoottacharn, K |
2023 |
Biochimica et biophysica acta. Molecular basis of disease (), pp. 166886 |
|
| 47. | Urinary metabolic profile and its predictive indexes after MSG consumption in rat. | Sukmak, M Kyaw, TS Nahok, K Sharma, A Silsirivanit, A Lert-Itthiporn, W Japrung, D Pinlaor, S Anutrakulchai, S Selmi, C Slupsky, CM Hammock, BD Cha'on, U |
2024 |
PloS one 9 (19), pp. e0309728 |
|
| 48. | Anilino-1,4-naphthoquinones as potent mushroom tyrosinase inhibitors: and studies. | Sabuakham, S Nasoontorn, S Kongtaworn, N Rungrotmongkol, T Silsirivanit, A Pingaew, R Mahalapbutr, P |
2024 |
Journal of enzyme inhibition and medicinal chemistry 1 (39), pp. 2357174 |
|
| 49. | Role of Wisteria floribunda agglutinin binding glycans in carcinogenesis and metastasis of cholangiocarcinoma. | Phuyathip, W Putthisen, S Panawan, O Ma-In, P Teeravirote, K Sintusen, P Udomkitkosol, S Detarya, M Luang, S Mahalapbutr, P Sato, T Kuno, A Chuangchaiya, S Silsirivanit, A |
2024 |
Histochemistry and cell biology 5 (161), pp. 423-434 |
|
| 50. | Chondroitin sulfate modification of CSPG4 regulates the maintenance and differentiation of glioma-initiating cells via integrin-associated signaling. | Niibori-Nambu, A Yamasaki, Y Kobayashi, D Angata, K Kuno, A Panawan, O Silsirivanit, A Narimatsu, H Araki, N |
2024 |
The Journal of biological chemistry 3 (300), pp. 105706 |
|
| 51. | Altered O-linked glycosylation in benign and malignant meningiomas. | Talabnin, C Trasaktaweesakul, T Jaturutthaweechot, P Asavaritikrai, P Kongnawakun, D Silsirivanit, A Araki, N Talabnin, K |
2024 |
PeerJ (12), pp. e16785 |
|
| 52. | Integration of RNAseq transcriptomics and -glycomics reveal biosynthetic pathways and predict structure-specific -glycan expression. | Alvarez, MRS Holmes, XA Oloumi, A Grijaldo-Alvarez, SJ Schindler, R Zhou, Q Yadlapati, A Silsirivanit, A Lebrilla, CB |
2025 |
Chemical science 17 (16), pp. 7155-7172 |
|
| 53. | Silencing of O-GlcNAc transferase attenuated O-GlcNAcylation and metastatic potentials of melanoma cells through suppression of Akt-NFkB signaling pathway. | Kanchanangkul, N Panawan, O Teeravirote, K Ma-In, P Mahalapbutr, P Luang, S Seubwai, W Lert-Itthiporn, W Kaewkong, W Vaeteewoottacharn, K Wongkham, S Roytrakul, S Silsirivanit, A |
2025 |
Chembiochem : a European journal of chemical biology (), pp. e202400896 |
|
| 54. | Serum N-Glycomics with Nano-LC-QToF LC-MS/MS Reveals N-Glycan Biomarkers for Glioblastoma, Meningioma, and High-Grade Meningioma. | Silsirivanit, A Alvarez, MRS Grijaldo-Alvarez, SJ Gogte, R Kitkhuandee, A Piyawattanametha, N Seubwai, W Luang, S Panawan, O Mahalapbutr, P Vaeteewoottacharn, K Sawanyawisuth, K Let-Itthiporn, W Saengboonmee, C Duangthongphon, P Jingjit, K Pankongsap, A Waraasawapati, S Aphivatanasiri, C Lebrilla, CB |
2025 |
Journal of proteome research 3 (24), pp. 1402-1413 |
|
| 55. | Clinical impacts of Artocarpus lakoocha agglutinin-binding glycans for prognosis and treatment of cholangiocarcinoma. | Sintusen, P Vaeteewoottacharn, K Cha'on, U Pairojkul, C Aphivatanasiri, C Suttiprapa, S Mahalapbutr, P Silsirivanit, A Wongkham, S Luang, S |
2025 |
Scientific reports 1 (15), pp. 436 |
|
| 56. | Discovery of -thiourea derivatives as potent tyrosinase inhibitors: combined experimental and computational study. | Sabuakham, S Nasoontorn, S Nuramrum, N Silsirivanit, A Rungrotmongkol, T Pingaew, R Mahalapbutr, P |
2025 |
Journal of enzyme inhibition and medicinal chemistry 1 (40), pp. 2518195 |
|
| 57. | Exploring Kidney Injury Molecule-1 and HAVCR1 Polymorphisms as Predictive Biomarkers in Chronic Kidney Disease. | Chaiyagot, N Silsirivanit, A Cha'on, U Jusakul, A Techasen, A Nahok, K Chamdam, A Anutrakulchai, S Lert-Itthiporn, W |
2025 |
Kidney diseases (Basel, Switzerland) 1 (11), pp. 342-355 |
|
| 58. | Soyasaponin-I Attenuates Melanogenesis through Activation of ERK and Suppression of PKA/CREB Signaling Pathways. | Ma-In, P Teeravirote, K Mahalapbutr, P Panawan, O Luang, S Silsirivanit, A |
2025 |
ACS omega 17 (10), pp. 18056-18061 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | A Novel Serum Carbohydrate Marker on Mucin 5AC Values for Diagnostic and Prognostic Indicators for Cholangiocarcinoma | Atit Silsirivanit Norie Araki Chaisiri Wongkham Chawalit Pairojkul Yoshiki Narimatsu Kazuhiko Kuwahara Hisashi Narimatsu Sopit Wongkham Nobuo Sakaguchi |
2011 |
CANCER 15.0 (117.0), pp. 3393.0-3403.0 |
41 | 0 | 0 | 0 | 0 | 0 | 41 | |
| 2. | Aberrant Glycosylation in Cholangiocarcinoma Demonstrated by Lectin-histochemistry | Somsiri Indramanee Atit Silsirivanit Chawalit Pairojkul Chaisiri Wongkham Sopit Wongkham |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 119.0-124.0 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 3. | A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: A potential marker for early diagnosis | Kanlayanee Sawanyawisuth Atit Silsirivanit Kunlathida Kunlabut Nattawat Tantapotinan Kulthida Vaeteewoottacharn Sopit Wongkham |
2012 |
PARASITOLOGY INTERNATIONAL 1.0 (61.0), pp. 151.0-154.0 |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
| 4. | Overexpression of O-GlcNAc-Transferase Associates with Aggressiveness of Mass-Forming Cholangiocarcinoma | Chatchai Phoomak Atit Silsirivanit Chaisiri Wongkham Banchob Sripa Anucha Puapairoj Sopit Wongkham |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 101.0-105.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 5. | Serum alpha(1)beta-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma | Arthit Tolek Chaisiri Wongkham Siriporn Proungvitaya Atit Silsirivanit Sittiruk Roytrakul Narong Khuntikeo Sopit Wongkham |
2012 |
EXPERIMENTAL BIOLOGY AND MEDICINE 10.0 (237.0), pp. 1142.0-1149.0 |
20 | 0 | 0 | 0 | 0 | 0 | 20 | |
| 6. | State of Serum Markers for Detection of Cholangiocarcinoma | Sopit Wongkham Atit Silsirivanit |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 17.0-27.0 |
27 | 0 | 0 | 0 | 0 | 0 | 27 | |
| 7. | TNP-470, A Methionine Aminopeptidase-2 Inhibitor, Inhibits Cell Proliferation, Migration and Invasion of Human Cholangiocarcinoma Cells In Vitro | Sonexai Kidoikhammouan Wunchana Seubwai Nattawat Tantapotinan Atit Silsirivanit Sopit Wongkham Kanlayanee Sawanyawisuth Chaisiri Wongkham |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 155.0-160.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 8. | CA-S27: A novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma | Atit Silsirivanit Norie Araki Chaisiri Wongkham Kulthida Vaeteewoottacharn Chawalit Pairojkul Kazuhiko Kuwahara Yoshiki Narimatsu Hiromichi Sawaki Hisashi Narimatsu Seiji Okada Nobuo Sakaguchi Sopit Wongkham |
2013 |
CANCER SCIENCE 10.0 (104.0), pp. 1278.0-1284.0 |
21 | 0 | 0 | 0 | 0 | 0 | 21 | |
| 9. | Comparison of microRNA (MiRNA) expression profiles between opisthorchis viverrini-associated cholangiocarcinoma (OV-CCA) and non-opisthorchis viverrini-associated cholangiocarcinoma (non-OV CCA) | Suebpong Tanasanvimon Asif Rashid Sopit Wongkham Chaitanya Churi Zhimin Tong David R. Fogelman Atit Silsirivanit Boris Blechacz Naruemon Klaikaew Vajarabhongsa Bhudhisawasdi Jean-Nicolas Vauthey Milind M. Javle |
2013 |
JOURNAL OF CLINICAL ONCOLOGY 4.0 (31.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 10. | Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches | Atit Silsirivanit Kanlayanee Sawanyawisuth Gregory J. Riggins Chaisiri Wongkham |
2014 |
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 6.0 (21.0), pp. 388.0-396.0 |
30 | 0 | 0 | 0 | 0 | 0 | 30 | |
| 11. | Tai Chi Improves Oxidative Stress Response and DNA Damage/Repair in Young Sedentary Females | Xing-Yu Huang Wichai Eungpinichpong Atit Silsirivanit Saowanee Nakmareong Xiu-Hua Wu |
2014 |
JOURNAL OF PHYSICAL THERAPY SCIENCE 6.0 (26.0), pp. 825.0-829.0 |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 12. | Effects of GUASHA on Heart Rate Variability in Healthy Male Volunteers under Normal Condition and Weightlifters after Weightlifting Training Sessions | Xingze Wang Uraiwan Chatchawan Saowanee Nakmareong Atit Silsirivanit Yingying Wang Dongbei Xie Jinsheng Yang Wichai Eungpinichpong |
2015 |
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (), pp. |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 13. | Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach | Sirorat Pattanapairoj Atit Silsirivanit Kanha Muisuk Wunchana Seubwai Ubon Cha'on Kulthida Vaeteewoottacharn Kanlayanee Sawanyawisuth Danaipong Chetchotsak Sopit Wongkham |
2015 |
CLINICAL BIOCHEMISTRY 10-11 (48.0), pp. 668.0-673.0 |
19 | 0 | 0 | 0 | 0 | 0 | 19 | |
| 14. | Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-kappa B | Chatchai Phoomak Kulthida Vaeteewoottacharn Kanlayanee Sawanyawisuth Wunchana Seubwai Chaisiri Wongkham Atit Silsirivanit Sopit Wongkham |
2016 |
SCIENTIFIC REPORTS (6.0), pp. |
28 | 0 | 0 | 0 | 0 | 0 | 28 | |
| 15. | YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma | Sunisa Thongsom Wethaka Chaocharoen Atit Silsirivanit Sopit Wongkham Banchob Sripa Han Choe Wipa Suginta Chutima Talabnin |
2016 |
TUMOR BIOLOGY 7.0 (37.0), pp. 9451.0-9463.0 |
25 | 0 | 0 | 0 | 0 | 0 | 25 | |
| 16. | High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation | Chatchai Phoomak Kulthida Vaeteewoottacharn Atit Silsirivanit Charupong Saengboonmee Wunchana Seubwai Kanlayanee Sawanyawisuth Chaisiri Wongkham Sopit Wongkham |
2017 |
SCIENTIFIC REPORTS (7.0), pp. |
76 | 0 | 0 | 0 | 0 | 0 | 76 | |
| 17. | Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells | Waraporn Saentaweesuk Norie Araki Kulthida Vaeteewoottacharn Atit Silsirivanit Wunchana Seubwai Chutima Talabnin Kanha Muisuk Banchob Sripa Sopit Wongkham Seiji Okada Chaisiri Wongkham |
2018 |
ONCOLOGY RESEARCH 4.0 (26.0), pp. 605.0-616.0 |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 18. | Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis | Waraporn Saentaweesuk Atit Silsirivanit Kulthida Vaeteewoottacharn Kanlayanee Sawanyawisuth Chawalit Pairojkul Ubon Cha'on Somsiri Indramanee Somchai Pinlaor Thidarut Boonmars Norie Araki Chaisiri Wongkham |
2018 |
CLINICA CHIMICA ACTA (477.0), pp. 66.0-71.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 19. | GaINAcylated glycans specific to Sophora japonica agglun in-Values for diagnosis and prognosis of cholangiocarcinoma | Kanlayanee Sawanyawisuth Waraporn Saentaweesuk Atit Silsirivanit Kulthida Vaeteewoottacharn Chawalit Pairojkul Ubon Cha-on Somsiri Indramanee Somchai Pinlaor Thidarut Boonmars Sopit Wongkham Chaisiri Wongkham |
2018 |
CANCER SCIENCE (109.0), pp. 253.0-253.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 20. | Heterogeneity of E-cadherin and vimentin expressing cells is essential for highly metastatic cholangiocarcinoma cells | Waraporn Saentaweesuk Norie Araki Atit Silsirivanit Kulthida Vaeteewoottacharn Sopit Wongkham Chaisiri Wongkham |
2018 |
CANCER SCIENCE (109.0), pp. 1028.0-1028.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 21. | Neutrophil to Lymphocyte Ratio as a diagnostic and prognostic marker for cholangiocarcinoma | Atit Silsirivanit Siriporn Tangwiboonpanich Waraporn Saentaweesuk Samrit Kamapatte Danaipong Chetchotesak Sopit Wongkham Chaisiri Wongkham |
2018 |
CANCER SCIENCE (109.0), pp. 502.0-502.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 22. | New evidence of connections between increased O-GlcNAcylation and inflammasome in the oral mucosa of patients with oral lichen planus | T. Thi Do C. Phoomak V. Champattanachai A. Silsirivanit P. Chaiyarit |
2018 |
CLINICAL AND EXPERIMENTAL IMMUNOLOGY 1.0 (192.0), pp. 129.0-137.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 23. | O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1 | Chatchai Phoomak Atit Silsirivanit Dayoung Park Kanlayanee Sawanyawisuth Kulthida Vaeteewoottacharn Chaisiri Wongkham Eric W. -F. Lam Chawalit Pairojkul Carlito B. Lebrilla Sopit Wongkham |
2018 |
ONCOGENE 42.0 (37.0), pp. 5648.0-5665.0 |
28 | 0 | 0 | 0 | 0 | 0 | 28 | |
| 24. | O-GlcNAcylation promotes metastasis of cholangiocarcinoma cells via suppression of FOXO3 expression | Chatchai Phoomak Atit Silsirivanit Kanlayanee Sawanyawisuth Kulthida Vaeteewoottacharn Chaisiri Wongkham Sopit Wongkham |
2018 |
CANCER SCIENCE (109.0), pp. 1114.0-1114.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 25. | Polypeptide N-acetylgalactosaminyltransferase 5 regulates growth and metastasis of cholangiocarcinoma | Marutpong Detarya Sriwipa Chuangchaiya Lukkana Sukprasert Atit Silsirivanit Kanlayanee Sawanyawisuth Sopit Wongkham Chaisiri Wongkham |
2018 |
CANCER SCIENCE (109.0), pp. 257.0-257.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 26. | Studies of key signals related to the maintenance and differentiation of glioma initiating cells by integrated-omics | Norie Araki Akiko N. Nambu Atit Silsirivanit Hiroki Okanishi Daiki Kobayashi Takuichiro Hide Hideo Nakamura |
2018 |
CANCER SCIENCE (109.0), pp. 630.0-630.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 27. | Blocking of methionine aminopeptidase-2 by TNP-470 induces apoptosis and increases chemosensitivity of cholangiocarcinoma | Sonexai Kidoikhammouan Wunchana Seubwai Atit Silsirivanit Sopit Wongkham Kanlayanee Sawanyawisuth Chaisiri Wongkham |
2019 |
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS 1.0 (15.0), pp. 148.0-152.0 |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 28. | Dependency of Cholangiocarcinoma on Cyclin D-Dependent Kinase Activity | Gunya Sittithumcharee Orawan Suppramote Kulthida Vaeteewoottacharn Chumphon Sirisuksakun Supawan Jamnongsong Phatthamon Laphanuwat Monthira Suntiparpluacha Arriya Matha Porncheera Chusorn Pongsakorn Buraphat Chumpot Kakanaporn Komgrid Charngkaew Atit Silsirivanit Krittiya Korphaisarn Somchai Limsrichamrern Npat Tripatara Chawalit Pairojkul Sopit Wongkham Somponnat Sampattavanich Seiji Okada Siwanon Jirawatnotai |
2019 |
HEPATOLOGY 5.0 (70.0), pp. 1614.0-1630.0 |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
| 29. | Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model | Kulthida Vaeteewoottacharn Chawalit Pairojkul Ryusho Kariya Kanha Muisuk Kanokwan Imtawil Yaovalux Chamgramol Vajarabhongsa Bhudhisawasdi Narong Khuntikeo Ake Pugkhem O-Tur Saeseow Atit Silsirivanit Chaisiri Wongkham Sopit Wongkham Seiji Okada |
2019 |
CELLS 5.0 (8.0), pp. |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 30. | Glycosylation markers in cancer | Atit Silsirivanit | 2019 |
ADVANCES IN CLINICAL CHEMISTRY, VOL 89 (89.0), pp. 189.0-213.0 |
35 | 0 | 0 | 0 | 0 | 0 | 35 | |
| 31. | Increase of MAL-II Binding Alpha2,3-Sialylated Glycan Is Associated with 5-FU Resistance and Short Survival of Cholangiocarcinoma Patients | Sasiprapa Wattanavises Atit Silsirivanit Kanlayanee Sawanyawisuth Ubon Cha'on Sakda Waraasawapati Waraporn Saentaweesuk Sukanya Luang Chalongchai Chalermwat Chaisiri Wongkham Sopit Wongkham |
2019 |
MEDICINA-LITHUANIA 12.0 (55.0), pp. |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 32. | Isocitrate dehydrogenase gene mutations and 2-hydroxyglutarate accumulation in esophageal squamous cell carcinoma | Keisuke Miyake Yoshifumi Baba Takatsugu Ishimoto Yukiharu Hiyoshi Masaaki Iwatsuki Yuji Miyamoto Naoya Yoshida Masayuki Watanabe Yoko Ogata Megumi Nagayama Atit Silsirivanit Daiki Kobayashi Norie Araki Hideo Baba |
2019 |
MEDICAL ONCOLOGY 1.0 (36.0), pp. |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 33. | Monosodium Glutamate (MSG) Renders Alkalinizing Properties and Its Urinary Metabolic Markers of MSG Consumption in Rats | Kanokwan Nahok Jia V. Li Jutarop Phetcharaburanin Hasina Abdul Chaisiri Wongkham Raynoo Thanan Atit Silsirivanit Sirirat Anutrakulchai Carlo Selmi Ubon Cha'on |
2019 |
BIOMOLECULES 10.0 (9.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 34. | O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma | Chatchai Phoomak Dayoung Park Atit Silsirivanit Kanlayanee Sawanyawisuth Kulthida Vaeteewoottacharn Marutpong Detarya Chaisiri Wongkham Carlito B. Lebrilla Sopit Wongkham |
2019 |
MOLECULAR ONCOLOGY 2.0 (13.0), pp. 338.0-357.0 |
20 | 0 | 0 | 0 | 0 | 0 | 20 | |
| 35. | Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients | Atit Silsirivanit Chatchai Phoomak Karuntarat Teeravirote Sasiprapa Wattanavises Wunchana Seubwai Charupong Saengboonmee Zhaoqi Zhan Jin-ichi Inokuchi Akemi Suzuki Sopit Wongkham |
2019 |
GLYCOCONJUGATE JOURNAL 2.0 (36.0), pp. 103.0-111.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 36. | Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma | Doungdean Tummanatsakun Tanakorn Proungvitaya Sittiruk Roytrakul Temduang Limpaiboon Sopit Wongkham Chaisiri Wongkham Atit Silsirivanit Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2019 |
BIOMOLECULES 9.0 (9.0), pp. |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 37. | Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway | Somsiri Indramanee Kanlayanee Sawanyawisuth Atit Silsirivanit Paweena Dana Chatchai Phoomak Ryusho Kariya Nathakan Klinhom-On Supannika Sorin Chaisiri Wongkham Seiji Okada Sopit Wongkham |
2019 |
SCIENTIFIC REPORTS (9.0), pp. |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 38. | Carbohydrate Antigen 50: Values for Diagnosis and Prognostic Prediction of Intrahepatic Cholangiocarcinoma | Sukanya Luang Karuntarat Teeravirote Waraporn Saentaweesuk Prasertsri Ma-In Atit Silsirivanit |
2020 |
MEDICINA-LITHUANIA 11.0 (56.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 39. | Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient | Banchob Sripa Wunchana Seubwai Kulthida Vaeteewoottacharn Kanlayanee Sawanyawisuth Atit Silsirivanit Worasak Kaewkong Kanha Muisuk Paweena Dana Chatchai Phoomak Worachart Lert-itthiporn Vor Luvira Chawalit Pairojkul Bin T. Teh Sopit Wongkham Seiji Okada Yaovalux Chamgramol |
2020 |
HUMAN CELL 3.0 (33.0), pp. 695.0-708.0 |
31 | 0 | 0 | 0 | 0 | 0 | 31 | |
| 40. | Kidney and urinary metabolic profiles of monosodium glutamate consumption in Wistar rats | Kanokwan Nahok Raynoo Thanan Atit Silsirivanit Carlo Selmi Ubon Cha'on |
2020 |
FASEB JOURNAL (34.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 41. | Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma | Atit Silsirivanit Atsushi Matsuda Atsushi Kuno Chikayuki Tsuruno Yuta Uenoyama Wunchana Seubwai Kiyohiko Angata Karuntarat Teeravirote Chaisiri Wongkham Norie Araki Youichi Takahama Sopit Wongkham Hisashi Narimatsu |
2020 |
CLINICA CHIMICA ACTA (510.0), pp. 142.0-149.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 42. | The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling | Marutpong Detarya Kanlayanee Sawanyawisuth Chaiwat Aphivatanasiri Sriwipa Chuangchaiya Paksiree Saranaruk Lukkana Sukprasert Atit Silsirivanit Norie Araki Sopit Wongkham Chaisiri Wongkham |
2020 |
GLYCOBIOLOGY 5.0 (30.0), pp. 312.0-324.0 |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 43. | A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Butea monosperma Agglutinin | Karuntarat Teeravirote Sukanya Luang Sakda Waraasawapati Patcharee Boonsiri Chaisiri Wongkham Sopit Wongkham Atit Silsirivanit |
2021 |
MOLECULES 9.0 (26.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 44. | Antioxidant and Cytotoxic Activity of Phellinus Mushrooms from Northeast Thailand | Sonesay Thammavong Methin Phadungkit Pornpun Laoyachirasuwan Khwanyuruan Naksuwanku Waraporn Saentaweesuk Atit Silsirivanit Sopit Wongkham |
2021 |
RESEARCH JOURNAL OF PHARMACOGNOSY 1.0 (8.0), pp. 91.0-99.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 45. | Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma | Prin Sungwan Worachart Lert-itthiporn Atit Silsirivanit Nathakan Klinhom-on Seiji Okada Sopit Wongkham Wunchana Seubwai |
2021 |
PEERJ (9.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 46. | Cyclin A is upregulated by high glucose and a potential target for cholangiocarcinoma patients with diabetes mellitus | Charupong Saengboonmee Wunchana Seubwai Sakkarn Sangkhamanon Marutpong Detarya Kanlayanee Sawanyawisuth Atit Silsirivanit Sopit Wongkham |
2021 |
CANCER SCIENCE (112.0), pp. 540.0-540.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 47. | Glycans: potential therapeutic targets for cholangiocarcinoma and their therapeutic and diagnostic implications | Atit Silsirivanit | 2021 |
EXPERT OPINION ON THERAPEUTIC TARGETS 1.0 (25.0), pp. 1.0-4.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 48. | Monosodium Glutamate Induces Changes in Hepatic and Renal Metabolic Profiles and Gut Microbiome of Wistar Rats | Kanokwan Nahok Jutarop Phetcharaburanin Jia Li Atit Silsirivanit Raynoo Thanan Piyanard Boonnate Jarus Joonhuathon Amod Sharma Sirirat Anutrakulchai Carlo Selmi Ubon Cha'on |
2021 |
NUTRIENTS 6.0 (13.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Biomarkers in Bile Duct Cancers: Current Status | Atit Silsirivanit Siriporn Proungvitaya Khon Kaen University - Faculty of Associated Medical Sciences Kanlayanee Sawanyawisuth Chaisiri Wongkham Sopit Wongkham Khon Kaen University - Liver Fluke and Cholangiocarcinoma Research Center |
2012 |
Srinagarind Medical Journal (27), pp. 405-412 |
|
| 2. | Sophora Japonica Agglutinin Reveals Aberrant Glycosylation in Cholangiocarcinoma | Waraporn Saentaweesuk Atit Silsirivanit Somsiri Indramanee Somchai Pinlaor Thidarut Boonmars Kulthida Vaeteewoottacharn Chaisiri Wongkham |
2013 |
Srinagarind Medical Journal (28 No 4), pp. 183 |
|
| 3. | Applications of Plant Lectins in Cholangiocarcinoma | Somsiri Indramanee Atit Silsirivanit Chawalit Pairojkul Chaisiri Wongkham Sopit Wongkham |
2013 |
Srinagarind Medical Journal (28 No 4), pp. 194 |
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ | ||
|---|---|---|---|---|---|---|
| 1. | การเพิ่มประสิทธิภาพการรักษามะเร็งท่อน้ำดีโดยการยับยั้งกระบวนการไกลโคซิเลชัน |
ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์ ศ.ดร. โสพิศ วงศ์คำ รศ.ดร. ชัยศิริ วงศ์คำ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2557 | ทุนงบประมาณแผ่นดินประจำปี 2557 | |
| 2. | การรักษาแบบมุ่งเป้าสำหรับผู้ป่วยมะเร็งท่อน้ำดี |
ศ.ดร. โสพิศ วงศ์คำ นายธนกร ปรุงวิทยา รศ.ดร. ชัยศิริ วงศ์คำ ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์ ศ.ดร. เต็มดวง ลิ้มไพบูลย์ ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ รศ.ดร. ศิริพร ปรุงวิทยา ผศ.ดร. วันชนะ สืบไวย |
ชุดโครงการวิจัย | 2557 | ทุนงบประมาณแผ่นดินประจำปี 2557 | |
| 3. | N-acetylgalactosaminyl transferases เป้าหมายเพื่อการรักษามะเร็งท่อน้ำดี |
ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์ ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์ ศ.ดร. โสพิศ วงศ์คำ รศ.ดร. ชัยศิริ วงศ์คำ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 4. | การค้นหาโมเลกุลเป้าหมายเพื่อการรักษามะเร็งท่อน้ำดีการค้นหาโมเลกุลเป้าหมายเพื่อการรักษามะเร็งท่อน้ำดี |
ศ.ดร. โสพิศ วงศ์คำ ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์ รศ.ดร. ศิริพร ปรุงวิทยา ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์ ผศ.ดร. วันชนะ สืบไวย นายธนกร ปรุงวิทยา นางสาวภัทรินทร์ โพธิพันธุ์ ดร. ปวีณา ดานะ นางสาวปิยะนาฏ บุญเนตร นางสาววรพร แสนทวีสุข นางสาวอัญชลี ต้นศรี นางสาวอุบลรัตน์ ธำรงวรางกูรนายมารุตพงศ์ นางสาวสมสิริ อินทรมณี ดร. จารุพงษ์ แสงบุญมี นายฉัตรชัย ภู่มาก ผศ.ดร. อุบล ชาอ่อน รศ.ดร. ชัยศิริ วงศ์คำ ศ.ดร. เต็มดวง ลิ้มไพบูลย์ |
ชุดโครงการวิจัย | 2561 | ทุนงบประมาณแผ่นดินประจำปี 2561 (งบบูรณาการวิจัยและนวัตกรรม) | |
| 5. | การพัฒนาการตรวจวินิจฉัยและการรักษามะเร็งท่อน้ำดีโดยโมเลกุลเป้าหมายแบบองค์รวม |
รศ.ดร. ศิริพร ปรุงวิทยา ศ.ดร. โสพิศ วงศ์คำ รศ.ดร. ชัยศิริ วงศ์คำ ศ.ดร. เต็มดวง ลิ้มไพบูลย์ ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์ ผศ.ดร. วันชนะ สืบไวย ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์ ผศ.ดร. อุบล ชาอ่อน นายธนกร ปรุงวิทยา ดร. สิทธิรักษ์ รอยตระกูล ดร. ปวีณา ดานะ นายฉัตรชัย ภู่มาก นางสาวภัคสิรี สรณารักษ์ น.ส. เสาวลักษณ์ สายสมบูรณ์ นายจิตรภาณุ มณีสาร นางสาววรพร แสนทวีสุข นางสาวศศิประภา วัฒนวิเศษ นางสาวกรัณฑรัตน์ ธีรวิโรจน์ นางสาวอรสา พนาวัน |
ชุดโครงการวิจัย | 2562 | ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม) | |
| 6. | ชุดตรวจตัวบ่งชี้ชีวภาพในเลือดแบบองค์รวมเพื่อวินิจฉัยและพยากรณ์โรค มะเร็งท่อน้ำดี |
ศ.ดร. โสพิศ วงศ์คำ รศ.ดร. ชัยศิริ วงศ์คำ รศ.ดร. ศิริพร ปรุงวิทยา ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์ ผศ.ดร. วันชนะ สืบไวย ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์ นายธนกร ปรุงวิทยา นางสาวศศิประภา วัฒนวิเศษ นางสาวกรัณฑรัตน์ ธีรวิโรจน์ |
โครงการ | 2562 | ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม) |